Omega Therapeutics Inc is a biotechnology company focused on developing and commercializing a new class of therapies known as epigenetic modulators
These innovative treatments aim to control gene expression and potentially address a range of diseases, including cancers and other serious health conditions. By leveraging their proprietary technology platform, Omega seeks to create precise and targeted therapies that can improve patient outcomes while minimizing side effects. The company is dedicated to advancing its research and development efforts to bring transformative solutions to the healthcare market.
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining over 100 points on Thursday. The Dow traded up 0.33% to 37,554.56 while the NASDAQ fell 0.10% to 14,578.04. The S&P 500 also rose, gaining, 0.09% to 4,708.93.
Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10. The S&P 500 also rose, gaining, 0.28% to 4,718.19.
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSELW) rose during Thursday’s session following better-than-expected quarterly results.
